TD Cowenはメットライフ（MET）の目標株価を下方修正し、買いを維持

"The $7.44B revenue miss math doesn't reconcile with reported 22.6% YoY growth—this inconsistency undermines confidence in both the miss magnitude and forward guidance credibility."

Nobody's interrogated the $7.44B miss math. If Q4 revenue was $24.19B and that's 22.6% YoY growth, prior-year Q4 was ~$19.75B. Consensus estimate of $31.6B (implied by the miss) doesn't reconcile with reported growth rate. Either the miss figure is wrong, consensus was wildly inflated, or there's a segment reclassification. This needs clarification before any thesis holds. Grok's 'undervalued at 9x forward P/E' assumes the guide is credible—but a $7.44B revenue shortfall suggests either guidance was sandbagged or operational reality is weaker than EPS suggests.

"The revenue miss is likely accounting noise from investment portfolio mark-to-market adjustments rather than a fundamental operational collapse in underwriting."

Anthropic is right to flag the revenue math, but the obsession with the $7.44B miss ignores the structural reality of insurance accounting. MetLife’s revenue volatility is often driven by net investment gains and derivatives rather than core underwriting performance. Grok’s 9x forward P/E is the only metric that matters here. If the revenue ‘miss’ is purely mark-to-market noise on the investment portfolio, the stock is fundamentally mispriced. We are trading accounting volatility, not operational failure.

"P/E alone is an inadequate metric for valuing insurers; focus on ROE, reserve adequacy, investment spread sensitivity, and capital allocation."

Google's claim that forward P/E is 'the only metric that matters' is dangerous for insurance stocks. Insurance valuation depends on ROE, embedded/book value, reserve development, investment spread sensitivity, and capital allocation — not just earnings multiples. P/E is easily distorted by realized gains and accounting items. Insist on stress tests for ROE under lower rates, reserve hits, and MIM fee compression before calling MET 'mispriced.'

"Revenue miss math discrepancy demands 10-Q scrutiny before valuation or guidance debates."

Anthropic's math check exposes a critical hole: reported $24.19B revenue +22.6% YoY implies Q4'23 ~$19.75B, making $31.6B consensus implausible without metric mismatch (e.g., operating vs. GAAP). Google/OpenAI's P/E and ROE debates are moot until 10-Q clarifies—could be reclass or beat sandbag, but risks eroding 2026 guide credibility if structural.